Rotavirus vaccines in Israel: Uptake and impact

References

• Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209-22; PMID:23680352; https://doi.org/10.1016/S0140-6736(13)60844-2
   PubMed Web of Science ®Google Scholar
• Forster J, Guarino A, Parez N, Moraga F, Roman E, Mory O, Tozzi AE, de Aguileta AL, Wahn U, Graham C, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009; 123:e393-400; PMID:19254975; https://doi.org/10.1542/peds.2008-2088
   PubMed Web of Science ®Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization-Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis 2016; 62 Suppl 2:S96-S105; PMID:27059362; https://doi.org/10.1093/cid/civ1013
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33; PMID:16394299; https://doi.org/10.1056/NEJMoa052664
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; https://doi.org/10.1056/NEJMoa052434
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14; PMID:20692030; https://doi.org/10.1016/S0140-6736(10)60889-6
   PubMed Web of Science ®Google Scholar
• Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec 2013; 88:49-64; PMID:23424730
   PubMedGoogle Scholar
• Tulchinsky TH, Burla E, Clayman M, Sadik C, Brown A, Goldberger S. Safety of community drinking-water and outbreaks of waterborne enteric disease: Israel, 1976–97. Bull World Health Organ 2000; 78:1466-73; PMID:11196499
   PubMed Web of Science ®Google Scholar
• Cohen D, Bassal R, Goren S, Rouach T, Taran D, Schemberg B, Peled N, Keness Y, Ken-Dror S, Vasilev V, et al. Recent trends in the epidemiology of shigellosis in Israel. Epidemiol Infect 2014; 142:2583-94; PMID:24559503; https://doi.org/10.1017/S0950268814000260
   PubMed Web of Science ®Google Scholar
• Levy A, Fraser D, Vardi H, Dagan R. Hospitalizations for infectious diseases in Jewish and Bedouin children in southern Israel. Eur J Epidemiol 1998; 14:179-86; PMID:9556178; https://doi.org/10.1023/A:1007439908351
   PubMed Web of Science ®Google Scholar
• Robin G, Fraser D, Orr N, Sela T, Slepon R, Ambar R, Dagan R, Le Blancq S, Deckelbaum RJ, Cohen D. Cryptosporidium infection in Bedouin infants assessed by prospective evaluation of anticryptosporidial antibodies and stool examination. Am J Epidemiol 2001; 153:194-201; PMID:11159166; https://doi.org/10.1093/aje/153.2.194
   PubMed Web of Science ®Google Scholar
• Gurovich N, Cohen-Kastro E. Ultra-orthodox Jews geographic distribution and demographic, social and economic characteristics of the ultra-orthodox Jewish population in Israel 1996–2001. Working paper series number 5. Jerusalem, Israel: Central Bureau of Statistics; 2004. (Hebrew).
   Google Scholar
• Swirski S, Hasson Y. Invisible citizens: Israeli government policy toward the Negev Bedouin, executive summary. Adva Center, information on equality and social justice in Israel. 2006. Available at: https://adva.org/wp-content/uploads/2014/09/NegevEnglishSummary.pdf
   Google Scholar
• Benifla M, Fraser D, Weizman Z, Levy A, Dagan R. Epidemiologic characteristics of pediatric emergency room referral and hospitalization for diarrhea in the Negev. Harefuah 1997; 132:534-8, 608; PMID:9153932
   PubMedGoogle Scholar
• Porath A, Lev B. The new Israeli national health insurance law and quality of care. Int J Qual Health Care 1995; 7:281-4; PMID:8595467
   PubMed Web of Science ®Google Scholar
• Dagan R, Bar-David Y, Sarov B, Katz M, Kassis I, Greenberg D, Glass RI, Margolis CZ, Sarov I. Rotavirus diarrhea in Jewish and Bedouin children in the Negev region of Israel: epidemiology, clinical aspects and possible role of malnutrition in severity of illness. Pediatr Infect Dis J 1990; 9:314-21; PMID:2162026; https://doi.org/10.1097/00006454-199005000-00003
   PubMed Web of Science ®Google Scholar
• Grisaru-Soen G, Engelhard D, Pearl S, Schlesinger Y, Shtein M, Ashkenazi S. Hospitalizations associated with rotavirus gastroenteritis in Israel-a retrospective study. Harefuah 2008; 147:8-11, 96; PMID:18300615
   PubMedGoogle Scholar
• Silberstein I, Shulman LM, Mendelson E, Shif I. Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli children. J Clin Microbiol 1995; 33:1421-2; PMID:7615771
   PubMed Web of Science ®Google Scholar
• Muhsen K, Shulman L, Rubinstein U, Kasem E, Kremer A, Goren S, Chodick G, Ephros M, Cohen D; TAU-HCLV Rota Study Group. Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of Israeli children <5 years of age, 2007–2008. J Infect Dis 2009; 200 Suppl 1:S254-63; PMID:19817606; https://doi.org/10.1086/605425
   PubMed Web of Science ®Google Scholar
• Givon-Lavi N, Ben-Shimol S, Cohen R, Greenberg D, Dagan R. Rapid impact of rotavirus vaccine introduction to the National Immunization Plan in Southern Israel: Comparison between 2 distinct populations. Vaccine 2015; 33(16):1934-40; PMID:25744226; https://doi.org/10.1016/j.vaccine.2015.02.062
   PubMed Web of Science ®Google Scholar
• Chodick G, Waisbourd-Zinman O, Shalev V, Kokia E, Rabinovich M, Ashkenazi S. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel. Eur J Public Health 2009; 19:254-9; PMID:19221026; https://doi.org/10.1093/eurpub/ckp005
   PubMed Web of Science ®Google Scholar
• Muhsen K, Chodick G, Goren S, Shalev V, Cohen D. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community. Vaccine 2010; 29:91-4; PMID:20969927; https://doi.org/10.1016/j.vaccine.2010.10.010
   PubMed Web of Science ®Google Scholar
• Muhsen K, Kassem E, Efraim S, Goren S, Cohen D, Ephros M. Incidence and risk factors for intussusception among children in northern Israel from 1992 to 2009: a retrospective study. BMC Pediatr 2014; 14:218; PMID:25174640; https://doi.org/10.1186/1471-2431-14-218
   PubMed Web of Science ®Google Scholar
• Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kolasa M. National, state, and selected local area vaccination coverage among children aged 19-35 months - United States, 2014. MMWR- Morb Mortal Wkly Rep 2015; 64:889-96; PMID:26313470; https://doi.org/10.15585/mmwr.mm6433a1
   PubMed Web of Science ®Google Scholar
• Hemming-Harlo M, Vesikari T, Uhari M, Renko M, Salminen M, Torcel-Pagnon L, Hartwig S, Simondon F, Bricout H. Sustained high effectiveness of RotaTeq on hospitalizations attributable to rotavirus-associated gastroenteritis during 4 years in Finland. J Pediatric Infect Dis Soc 2016; pii: piw061; [Epub ahead of print]; PMID:27760800; https://doi.org/10.1093/jpids/piw061
   PubMedGoogle Scholar
• Muhsen K, Rubenstein U, Kassem E, Goren S, Schachter Y, Kremer A, Shulman LM, Ephros M, Cohen D. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel. Hum Vaccin Immunother 2015; 11:2475-82; PMID:26212174; https://doi.org/10.1080/21645515.2015.1056951
   PubMed Web of Science ®Google Scholar
• Muhsen K, Kassem E, Rubenstein U, Goren S, Ephros M, Cohen D, Shulman LM. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel. Vaccine 2016; 34:5916-22; PMID:27771186; https://doi.org/10.1016/j.vaccine.2016.10.021
   PubMed Web of Science ®Google Scholar
• Muhsen K, Chodick G, Goren S, Anis E, Ziv-Baran T, Shalev V, Cohen D. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel. Euro Surveill 2015; 20(42); PMID:26538450; https://doi.org/10.2807/1560-7917.ES.2015.20.42.30045
   PubMedGoogle Scholar
• Muhsen K, Shulman L, Kasem E, Rubinstein U, Shachter J, Kremer A, Goren S, Zilberstein I, Chodick G, Ephros M, et al. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: A case-control study. Hum Vaccin 2010; 6:450-4; PMID:20448471; https://doi.org/10.4161/hv.6.6.11759
   PubMed Web of Science ®Google Scholar
• Leshem E, Givon-Lavi N, Tate JE, Greenberg D, Parashar UD, Dagan R. Real-world effectiveness of pentavalent rotavirus vaccine among Bedouin and Jewish children in Southern Israel. Clin Infect Dis 2016; 62:S155-S60; PMID:27059350; https://doi.org/10.1093/cid/civ1012
   PubMed Web of Science ®Google Scholar
• Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD; National Rotavirus Strain Surveillance System. United States rotavirus strain surveillance from 2005 to 2008: genotypeprevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30:S42-S7; PMID:21183839; https://doi.org/10.1097/INF.0b013e3181fefd78
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix (R) and RotaTeq (R), into the national immunization program of Australia. Pediatr Infect Dis J 2011; 30:S48-53; PMID:21183840; https://doi.org/10.1097/INF.0b013e3181fefd90
   PubMed Web of Science ®Google Scholar